White matter NAA/Cho and Cho/Cr ratios at MR spectroscopy are predictive of motor outcome in preterm infants

Radiology

Volumn 271, Issue 1, 2014, Pages 230-238

  Kendall, Giles S ^a   Melbourne, Andrew ^a   Johnson, Samantha ^b   Price, David ^c   Bainbridge, Alan ^c   Gunny, Roxanna ^d   Huertas Ceballos, Angela ^a   Cady, Ernest B ^c   Ourselin, Sebastian ^a   Marlow, Neil ^a   Robertson, Nicola J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHOLINE; N ACETYLASPARTIC ACID; ASPARTIC ACID; CREATINE; N-ACETYLASPARTATE;

AREA UNDER THE CURVE; ARTICLE; BAYLEY SCALES OF INFANT DEVELOPMENT; BRAIN REGION; CHOLINE TO CREATININE RATIO; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPOSITE COGNITIVE SCORE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FRACTIONAL ANISOTROPY; GESTATIONAL AGE; GROSS MOTOR SCORE; HUMAN; INFANT; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREMATURITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOLOGICAL PARAMETERS; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; ANALOGS AND DERIVATIVES; CHILD DEVELOPMENT; METABOLISM; MOTOR PERFORMANCE; MYELINATED NERVE; NEWBORN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES;

ASPARTIC ACID; CHILD DEVELOPMENT; CHOLINE; CREATINE; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MOTOR SKILLS; NERVE FIBERS, MYELINATED;

EID: 84896985731     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13122679     Document Type: Article

References (44)

1. Bax M, Tydeman C, Flodmark O. Clinical and MRI correlates of cerebral palsy: the European Cerebral Palsy Study. JAMA 2006;296(13):1602-1608. (Pubitemid 44511607)
2. Himpens E, Van den Broeck C, Oostra A, Calders P, Vanhaesebrouck P. Prevalence, type, distribution, and severity of cerebral palsy in relation to gestational age: a meta-analytic review. Dev Med Child Neurol 2008;50(5):334-340. (Pubitemid 351560292)
3. Spittle AJ, Cheong J, Doyle LW, et al. Neonatal white matter abnormality predicts childhood motor impairment in very preterm children. Dev Med Child Neurol 2011;53(11):1000-1006.
4. Maalouf EF, Duggan PJ, Rutherford MA, et al. Magnetic resonance imaging of the brain in a cohort of extremely preterm infants. J Pediatr 1999;135(3):351-357. (Pubitemid 30180510)
5. Boardman JP, Craven C, Valappil S, et al. A common neonatal image phenotype predicts adverse neurodevelopmental outcome in children born preterm. Neuroimage 2010;52(2):409-414.
6. Hagmann CF, De Vita E, Bainbridge A, et al. T2 at MR imaging is an objective quantitative measure of cerebral white matter signal intensity abnormality in preterm infants at term-equivalent age. Radiology 2009;252(1):209-217.
7. Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and develonce opmental disturbances. Lancet Neurol 2009;8(1):110-124.
8. Woodward LJ, Anderson PJ, Austin NC, Howard K, Inder TE. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. N Engl J Med 2006;355(7):685-694.
9. Ment LR, Hirtz D, Hüppi PS. Imaging biomarkers of outcome in the developing preterm brain. Lancet Neurol 2009;8(11):1042-1055.
10. Back SA, Riddle A, McClure MM. Maturation-dependent vulnerability of perinatal white matter in premature birth. Stroke 2007;38(2 Suppl):724-730. (Pubitemid 46184249)
11. Banker BQ, Larroche JC. Periventricular leukomalacia of infancy: a form of neonatal anoxic encephalopathy. Arch Neurol 1962;7:386-410.
12. Buser JR Jr, Maire J, Riddle A, et al. Arrested preoligodendrocyte maturation contributes to myelination failure in premature infants. Ann Neurol 2012;71(1):93-109.
13. Volpe JJ, Kinney HC, Jensen FE, Rosenberg PA. The developing oligodendrocyte: key cellular target in brain injury in the premature infant. Int J Dev Neurosci 2011;29(4):423-440.
14. Riddle A, Dean J, Buser JR, et al. Histopathological correlates of magnetic resonance imaging-defined chronic perinatal white matter injury. Ann Neurol 2011;70(3):493-507.
15. Riddle A, Luo NL, Manese M, et al. Spatial heterogeneity in oligodendrocyte lineage maturation and not cerebral blood flow predicts fetal ovine periventricular white matter injury. J Neurosci 2006;26(11):3045-3055.
16. Sturrock A, Laule C, Decolongon J, et al. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology 2010;75(19):1702-1710.
17. Paul RH, Yiannoutsos CT, Miller EN, et al. Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. J Neuropsychiatry Clin Neurosci 2007;19(3):283-292. (Pubitemid 47293901)
18. Narayana PA. Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. J Neuroimaging 2005;15(4 Suppl):46S-57S. (Pubitemid 43010531)
19. Brooks WM, Friedman SD, Gasparovic C. Magnetic resonance spectroscopy in traumatic brain injury. J Head Trauma Rehabil 2001;16(2):149-164. (Pubitemid 32319512)
20. Karaszewski B, Thomas RG, Chappell FM, et al. Brain choline concentration: early quantitative marker of ischemia and infarct expansion? Neurology 2010;75(10):850-856.
21. 1H MR spectroscopic measures of brain choline/creatine and myo-inositol/creatine in a primate model. AJNR Am J Neuroradiol 2005;26(4):752-759.
22. Inder TE, Wells SJ, Mogridge NB, Spencer C, Volpe JJ. Defining the nature of the cerebral abnormalities in the premature infant: a qualitative magnetic resonance imaging study. J Pediatr 2003;143(2):171-179. (Pubitemid 37082947)
23. Pierpaoli C, Basser PJ. Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 1996;36(6):893-906. (Pubitemid 26396817)
24. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129(1):35-43. (Pubitemid 127454051)
25. Stefan D, Di Cesare F, Andrasescu A, et al. Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package. Meas Sci Technol 2009;20(10):104035.
26. Bayley N. Bayley scales of infant and toddler development. 3rd ed. San Antonio, Tex: Harcourt Assessment, 2005.
27. Moore T, Johnson S, Haider S, Hennessy E, Marlow N. Relationship between test scores using the second and third editions of the Bayley scales in extremely preterm children. J Pediatr 2012;160(4):553-558.
28. Xu D, Bonifacio SL, Charlton NN, et al. MR spectroscopy of normative premature newborns. J Magn Reson Imaging 2011;33(2):306-311.
29. Bartha AI, Yap KR, Miller SP, et al. The normal neonatal brain: MR imaging, diffusion tensor imaging, and 3D MR spectroscopy in healthy term neonates. AJNR Am J Neuroradiol 2007;28(6):1015-1021. (Pubitemid 46984532)
30. Kreis R, Hofmann L, Kuhlmann B, Boesch C, Bossi E, Hüppi PS. Brain metabolite compostition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2002;48(6):949-958. (Pubitemid 35398524)
31. Kimura H, Fujii Y, Itoh S, et al. Metabolic alterations in the neonate and infant brain during development: evaluation with proton MR spectroscopy. Radiology 1995;194(2):483-489.
32. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30(4):424-437. (Pubitemid 23300070)
33. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM. N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 2007;81(2):89-131. (Pubitemid 46282272)
34. Johnson S. Cognitive and behavioural outcomes following very preterm birth. Semin Fetal Neonatal Med 2007;12(5):363-373. (Pubitemid 47393662)
35. Augustine EM, Spielman DM, Barnes PD, et al. Can magnetic resonance spectroscopy predict neurodevelopmental outcome in very low birth weight preterm infants? J Perinatol 2008;28(9):611-618.
36. Hashimoto T, Tayama M, Miyazaki M, et al. Reduced N-acetylaspartate in the brain observed on in vivo proton magnetic resonance spectroscopy in patients with mental retardation. Pediatr Neurol 1995;13(3):205-208.
37. Filippi CG, Ulu? AM, Deck MD, Zimmerman RD, Heier LA. Developmental delay in children: assessment with proton MR spectroscopy. AJNR Am J Neuroradiol 2002;23(5):882-888. (Pubitemid 34525712)
38. Martin E, Keller M, Ritter S, Largo RH, Thiel T, Loenneker T. Contribution of proton magnetic resonance spectroscopy to the evaluation of children with unexplained developmental delay. Pediatr Res 2005;58(4):754-760. (Pubitemid 41368909)
39. Haynes RL, Billiards SS, Borenstein NS, Volpe JJ, Kinney HC. Diffuse axonal injury in periventricular leukomalacia as determined by apoptotic marker fractin. Pediatr Res 2008;63(6):656-661.
40. Riddle A, Maire J, Gong X, et al. Differential susceptibility to axonopathy in necrotic and non-necrotic perinatal white matter injury. Stroke 2012;43(1):178-184.
41. Back SA, Luo NL, Mallinson RA, et al. Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes. Ann Neurol 2005;58(1):108-120. (Pubitemid 40962466)
42. Hüppi PS, Dubois J. Diffusion tensor imaging of brain development. Semin Fetal Neonatal Med 2006;11(6):489-497. (Pubitemid 44666595)
43. Counsell SJ, Shen Y, Boardman JP, et al. Axial and radial diffusivity in preterm infants who have diffuse white matter changes on magnetic resonance imaging at term-equivalent age. Pediatrics 2006;117(2):376-386. (Pubitemid 46071599)
44. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 2006;240(2):318-332.